Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis
- 12 November 2016
- journal article
- research article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 21 (2), 125-135
- https://doi.org/10.1007/s40291-016-0245-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Quantification of Maternal Serum Cell-Free Fetal DNA in Early-Onset PreeclampsiaInternational Journal of Molecular Sciences, 2013
- Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell‐free fetal DNATransfusion, 2013
- Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restrictionPrenatal Diagnosis, 2009
- Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Pre-eclampsiaThe Lancet, 2005
- Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newbornVox Sanguinis, 2004
- Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low‐risk nonsymptomatic patientsPrenatal Diagnosis, 2004
- THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIAHypertension in Pregnancy, 2002